Literature DB >> 17114578

The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry.

Anil K Rustgi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114578     DOI： 10.1101/gad.1501106

Source DB:  PubMed          Journal:  Genes Dev        ISSN： 0890-9369            Impact factor:   11.361


× No keyword cloud information.
  15 in total

1.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

Review 2.  Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Authors:  Günter Schneider; Oliver H Krämer; Roland M Schmid; Dieter Saur
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 3.  Advances in biomarker research for pancreatic cancer.

Authors:  Kruttika Bhat; Fengfei Wang; Qingyong Ma; Qinyu Li; Sanku Mallik; Tze-Chen Hsieh; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity.

Authors:  Shiv K Singh; Nai-Ming Chen; Elisabeth Hessmann; Jens Siveke; Marlen Lahmann; Garima Singh; Nadine Voelker; Sophia Vogt; Irene Esposito; Ansgar Schmidt; Cornelia Brendel; Thorsten Stiewe; Jochen Gaedcke; Marco Mernberger; Howard C Crawford; William R Bamlet; Jin-San Zhang; Xiao-Kun Li; Thomas C Smyrk; Daniel D Billadeau; Matthias Hebrok; Albrecht Neesse; Alexander Koenig; Volker Ellenrieder
Journal:  EMBO J       Date:  2015-01-13       Impact factor: 11.598

5.  Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.

Authors:  Jian-Xin Jiang; Cheng-Yi Sun; She Tian; Chao Yu; Mei-Yuan Chen; Hao Zhang
Journal:  Tumour Biol       Date:  2016-08-03

6.  An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

Authors:  Jungsun Kim; John P Hoffman; R Katherine Alpaugh; Andrew D Rhim; Andrew D Rhimm; Maximilian Reichert; Ben Z Stanger; Emma E Furth; Antonia R Sepulveda; Chao-Xing Yuan; Kyoung-Jae Won; Greg Donahue; Jessica Sands; Andrew A Gumbs; Kenneth S Zaret
Journal:  Cell Rep       Date:  2013-06-20       Impact factor: 9.423

7.  MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling.

Authors:  Seth B Krantz; Mario A Shields; Surabhi Dangi-Garimella; Eric C Cheon; Morgan R Barron; Rosa F Hwang; M Sambasiva Rao; Paul J Grippo; David J Bentrem; Hidayatullah G Munshi
Journal:  Mol Cancer Res       Date:  2011-08-19       Impact factor: 5.852

8.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Authors:  Sugiko Watanabe; Yasuaki Ueda; Shin-ichi Akaboshi; Yuko Hino; Yoko Sekita; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

9.  GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.

Authors:  Olivier Nolan-Stevaux; Janet Lau; Morgan L Truitt; Gerald C Chu; Matthias Hebrok; Martin E Fernández-Zapico; Douglas Hanahan
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

10.  Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.

Authors:  Meritxell Huch; Alena Gros; Anabel José; Juan Ramon González; Ramon Alemany; Cristina Fillat
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.